Notice of Intent  The Genetic Diseases Program is proposing to amend its existing rule to add an additional test to the newborn screening panel to test for Severe Combined Immunodeficiency.  In accordance with the Administrative Procedure Act, notice is here by provided that a copy of the proposed rule has been delivered on July 10, 2018 to the legislative oversight committees which oversee LDH rulemaking.  

The major amendment to the existing Newborn Heel Stick Screening rule proposes to add Severe Combined Immunodeficiency (SCID) to the panel of tests all newborns are screened for in Louisiana. Secondarily, the proposed rule updates procedures to reflect modern laboratory methodologies and to update current addresses, phone numbers and fax numbers. Finally, a proposed amendment to the lab fee rule will make the Newborn Screening Panel lab test fee consistent with the fee currently collected by the Newborn Heel Stick Screening program.

The current rule can be found on the Division of Administration Office of the State Register website under LAC 48, Part V in Book 2 of 2.

Click here to visit the DOA OSR website.

Click here to view a copy of the proposed Newborn Heel Stick Screening rule which is coded with any new rule language that is to be added to the existing rule underscored and any language that is to be deleted from the existing agency rule in struck-through type.

The expected publication date of the Notice of Intent (NOI) in the Louisiana Register is July 20, 2018.

The anticipated effective date of the proposed rule is October 20, 2018.